We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+2.3%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$741M
AUM Growth
+$38.7M
Cap. Flow
+$31.5M
Cap. Flow %
4.25%
Top 10 Hldgs %
60.64%
Holding
104
New
35
Increased
22
Reduced
3
Closed
10

Top Buys

Rank Stock Value
1
WAB icon
Wabtec
WAB
+$12.3M
2
WAT icon
Waters Corp
WAT
+$9M
3
DO
Diamond Offshore Drilling
DO
+$6.09M
4
GILD icon
Gilead Sciences
GILD
+$5.17M
5
RTX icon
RTX Corp
RTX
+$4.82M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$27.9M
2
CSCO icon
Cisco
CSCO
+$2.32M
3
LGND icon
Ligand Pharmaceuticals
LGND
+$1.06M
4
UTHR icon
United Therapeutics
UTHR
+$1.05M
5
DBVT
DBV Technologies
DBVT
+$1.03M

Sector Composition

Rank Sector Weight
1 Financials 38.94%
2 Healthcare 24.52%
3 Industrials 11.96%
4 Technology 10.74%
5 Energy 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASHR icon
51
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
$968K 0.13%
+35,500
New +$902K
OPK icon
52
Opko Health
OPK
$1.04B
$917K 0.12%
139,405
+50,000
+56% +$350K
DNOW icon
53
DNOW Inc
DNOW
$3.01B
$895K 0.12%
55,675
– –
DVAX
54
DELISTED
Dynavax Technologies
DVAX
$808K 0.11%
83,755
+33,755
+68% +$219K
ACOR
55
DELISTED
Acorda Therapeutics
ACOR
$703K 0.09%
297
+214
+258% +$424K
BIVV
56
DELISTED
Bioverativ Inc. Common Stock
BIVV
$662K 0.09%
11,000
– –
AIMT
57
DELISTED
Aimmune Therapeutics
AIMT
$617K 0.08%
+30,000
New +$572K
ALXN
58
DELISTED
Alexion Pharmaceuticals
ALXN
$608K 0.08%
+5,000
New +$582K
TGTX icon
59
TG Therapeutics
TGTX
$7.64B
$603K 0.08%
60,000
– –
ANIP icon
60
ANI Pharmaceuticals
ANIP
$1.71B
$568K 0.08%
12,130
+7,130
+143% +$344K
SYNT
61
DELISTED
Syntel Inc
SYNT
$530K 0.07%
31,270
+11,570
+59% +$201K
ALDX icon
62
Aldeyra Therapeutics
ALDX
$91.1M
$507K 0.07%
107,858
+70,196
+186% +$323K
EIGR
63
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$482K 0.07%
2,033
+1,689
+491% +$384K
L icon
64
Loews
L
$23.1B
$454K 0.06%
+9,700
New +$454K
VWO icon
65
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$449K 0.06%
+11,000
New +$446K
OCRX
66
DELISTED
Ocera Therapeutics, Inc.
OCRX
$437K 0.06%
376,596
+126,596
+51% +$147K
MRTX
67
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$365K 0.05%
+100,000
New +$383K
CYOU
68
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$284K 0.04%
+7,340
New +$252K
ECL icon
69
Ecolab
ECL
$79.8B
$279K 0.04%
+2,100
New +$271K
AKTX
70
Akari Therapeutics
AKTX
$13.5M
$277K 0.04%
+75
New +$593K
BBY icon
71
Best Buy
BBY
$17.6B
$233K 0.03%
+4,060
New +$217K
SGI
72
Somnigroup International
SGI
$13.7B
$232K 0.03%
+17,400
New +$205K
USNA icon
73
Usana Health Sciences
USNA
$254M
$221K 0.03%
+3,440
New +$212K
TUP
74
DELISTED
Tupperware Brands Corporation
TUP
$220K 0.03%
+3,130
New +$218K
BBWI icon
75
Bath & Body Works
BBWI
$3.81B
$219K 0.03%
+5,035
New +$206K
1 2
3
4 5

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q2 2017 Portfolio in Review

As of Q2 2017, Hikari Power held 104 positions worth $741M, up 5.5% from $703M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Hikari Power deployed $31.5M of net new capital in Q2 2017, opening 35 new positions and adding to 22 existing holdings. Its largest new stake was Waters Corp: 51,800 shares worth $9.52M.

By sector, the portfolio is most concentrated in Financials at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was IBM, an estimated $27.9M trimmed.

  • Hikari Power's largest Q2 2017 buy was Waters Corp: 51,800 shares worth $9.52M.
  • Hikari Power added most to Wabtec in Q2 2017, an estimated $12.3M increase.
  • Hikari Power's biggest Q2 2017 reduction was IBM, cutting an estimated $27.9M.
  • Hikari Power fully exited Ligand Pharmaceuticals in Q2 2017, selling an estimated $1.06M.
  • Hikari Power's ten largest holdings make up 61% of its $741M portfolio in Q2 2017.
  • Hikari Power opened 35 new positions and closed 10 in Q2 2017.
  • Hikari Power's portfolio value rose 5.5% quarter-over-quarter to $741M.

Based on Hikari Power's 13F filing for Q2 2017, filed 9 Aug 2017.